Qin Lulu, Wang Wen-Jin, Xia Xinyi, Zuo Tongshan, Cai Yilin, Xu Guanhong, Wei Fangdi, Wang Suling, Hu Qin, Zhao Zheng, Zhang Fan, Tang Ben Zhong, Cen Yao
School of Pharmacy, Nanjing Medical University Nanjing Jiangsu 211166 China.
Clinical Translational Research Center of Aggregation-Induced Emission, School of Medicine, The Second Affiliated Hospital, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong Shenzhen (CUHK-Shenzhen) Guangdong 518172 China.
Chem Sci. 2025 Jun 16. doi: 10.1039/d5sc02575c.
The CRISPR/Cas12a system has demonstrated extraordinary capabilities in biosensing and molecular diagnostics, owing to its precise recognition and efficient -cleavage ability. However, current crRNA-based Cas12a regulation is relatively crude, requiring costly modifications and multiple components, increasing system complexity. Here, we develop translesion synthesis-driven hierarchical regulation using a template-activator construct for Cas12a activity (THRUST), a powerful and economical Cas12a regulation strategy. This strategy utilizes a bifunctional template-activator construct (TAC) that simultaneously functions as a transcriptional template for T7 RNA polymerase (T7 RNAP) and an activator for Cas12a. T7 RNAP skips the deoxyuridine (dU) lesion while being blocked by the apurinic/apyrimidinic (AP) site. Strategic positioning of transcriptional regulatory units on the TAC allows precise control of crRNA length and simultaneously regulates Cas12a activation at the activator level, thereby achieving hierarchical regulation of Cas12a. Through the construction of "Dim down" and "Light up" biosensing platforms and an aggregation-induced emission lateral flow test, THRUST enriches the CRISPR/Cas12a regulatory toolbox for molecular diagnostics.
CRISPR/Cas12a系统凭借其精确识别和高效切割能力,在生物传感和分子诊断领域展现出非凡的能力。然而,目前基于crRNA的Cas12a调控相对粗糙,需要进行昂贵的修饰且涉及多个组件,增加了系统的复杂性。在此,我们开发了一种利用模板激活构建体调控Cas12a活性的跨损伤合成驱动分层调控方法(THRUST),这是一种强大且经济的Cas12a调控策略。该策略利用一种双功能模板激活构建体(TAC),它同时作为T7 RNA聚合酶(T7 RNAP)的转录模板和Cas12a的激活剂。T7 RNAP在被无嘌呤/无嘧啶(AP)位点阻断时会跳过脱氧尿苷(dU)损伤。转录调控单元在TAC上的策略性定位允许精确控制crRNA长度,并同时在激活剂水平调节Cas12a的激活,从而实现对Cas12a的分层调控。通过构建“调暗”和“点亮”生物传感平台以及一种聚集诱导发光侧向流动检测方法,THRUST丰富了用于分子诊断的CRISPR/Cas12a调控工具箱。